Compounds > dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination
Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and lysophosphatidylcholines

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with lysophosphatidylcholines in 1 studies

Compound Research Comparison

Studies
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)		Trials
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)		Recent Studies (post-2010)
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)		Studies
(lysophosphatidylcholines)		Trials
(lysophosphatidylcholines)		Recent Studies (post-2010) (lysophosphatidylcholines)
2198435,05839976

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belik, J; Duncan, JE; Hatch, GM1

Other Studies

1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and lysophosphatidylcholines

ArticleYear
Susceptibility of exogenous surfactant to phospholipase A2 degradation.
    Canadian journal of physiology and pharmacology, 1996, Volume: 74, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetylation; Animals; Biological Products; Cattle; Chemistry, Pharmaceutical; Drug Combinations; Fatty Alcohols; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Phospholipases A; Phospholipases A2; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants

1996